Department of Dermatology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Br J Dermatol. 2011 Jun;164(6):1256-61. doi: 10.1111/j.1365-2133.2011.10345.x.
Moderate to severe psoriasis is associated with increased alcohol intake and excessive mortality from alcohol-related causes. Alcohol biomarkers provide an objective measure of alcohol consumption. Carbohydrate-deficient transferrin (CDT) is the single most sensitive and specific alcohol biomarker.
To assess alcohol consumption in a cohort of patients with moderate to severe psoriasis using standard alcohol screening questionnaires and biomarkers. We investigated whether there was an association between alcohol intake, anxiety, depression and disease severity.
Consecutive patients with chronic plaque psoriasis were recruited and completed a range of anonymized assessments. Psoriasis severity, anxiety and depression, and the impact of psoriasis on quality of life were assessed. Alcohol screening questionnaires were administered. Blood specimens were taken and γ-glutamyltransferase (γGT) and CDT were measured.
A total of 135 patients completed the study. Using validated questionnaires, between 22% and 32% had difficulties with alcohol. Seven per cent had CDT > 1·6% indicating a heavy alcohol intake. The Alcohol Use Disorders Identification Test (AUDIT) questionnaire was superior to other validated questionnaires in detecting alcohol misuse. There were no significant associations between measures of excessive alcohol consumption and disease severity. Excessive alcohol intake as measured by the CAGE questionnaire was associated with increased depression (P = 0·001) but other measures of alcohol excess did not correlate with psychological distress. Men had significantly more difficulties with alcohol than women (P < 0·001).
Alcohol misuse is common in patients with moderate to severe psoriasis. Screening with the AUDIT questionnaire and CDT may allow the identification of patients who are misusing alcohol and allow appropriate intervention.
中重度银屑病与饮酒量增加和酒精相关原因导致的死亡率过高有关。酒精生物标志物可客观衡量饮酒量。转铁蛋白缺乏(CDT)是最敏感和最特异的酒精生物标志物。
使用标准酒精筛查问卷和生物标志物评估中重度银屑病患者的饮酒情况。我们研究了饮酒量与焦虑、抑郁和疾病严重程度之间是否存在关联。
连续招募患有慢性斑块状银屑病的患者,并完成一系列匿名评估。评估银屑病严重程度、焦虑和抑郁以及银屑病对生活质量的影响。进行酒精筛查问卷。采集血样并测量γ-谷氨酰转移酶(γGT)和 CDT。
共有 135 名患者完成了研究。使用经过验证的问卷,22%至 32%的患者存在饮酒困难。7%的患者 CDT>1·6%,表明其存在大量饮酒。酒精使用障碍识别测试(AUDIT)问卷在检测酒精滥用方面优于其他经过验证的问卷。过量饮酒与疾病严重程度之间无显著相关性。CAGE 问卷衡量的过量饮酒与抑郁增加有关(P=0·001),但其他衡量酒精过量的指标与心理困扰无关。男性饮酒困难明显多于女性(P<0·001)。
中重度银屑病患者中酒精滥用很常见。使用 AUDIT 问卷和 CDT 筛查可能有助于识别滥用酒精的患者,并进行适当干预。